Delivery Order SPE2DB20D1109-SPE2DB25FN32V
Award Date
12/31/24
Potential Completion Date
1/2/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,537.92 firm fixed price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. This award is a part of Amerisourcebergen's larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $6,994.44, is for the delivery of Revatio 20 mg tablets, a medication used to treat pulmonary arterial hypertension.
The contract is a Delivery Order with a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating it was awarded on a full and open competition basis. The contract has an ultimate completion...
This federal contract award, valued at $33,538.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has a firm fixed price and an ultimate completion date of October 24, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,549.85 firm-fixed-price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product, with a completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, with the identifier SPE2DB22D2206|SPE2DB25FEW58, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,648.24 firm-fixed-price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension.
The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $21,316.74 delivery order is for the supply of Revatio 20 mg tablets, a medication used to treat pulmonary arterial hypertension. This award is a firm fixed-price contract with an ultimate completion date of August 5, 2024. The contract has no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds several...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $39,996.51 firm-fixed-price contract is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension.
The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order. The contract has an ultimate...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $28,002.89 firm fixed price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a prescription medication, to support military treatment programs and facilities. The contract does not have a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 20 mg REVATIO tablets. The $36,926.35 firm fixed-price contract has an ultimate completion date of October 21, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $2,331.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product.
The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 12, 2024. It is not designated with any set-aside requirements, indicating open...